Trial Outcomes & Findings for Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction (NCT NCT03105518)
NCT ID: NCT03105518
Last Updated: 2022-08-03
Results Overview
Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale). VAS scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort.
UNKNOWN
PHASE4
100 participants
PACU admission, 15, 30 and 60 min postprocedure, postoperative day 3
2022-08-03
Participant Flow
Participant milestones
| Measure |
Analgesia Options
Protocolized analgesia based on VAS degree of discomfort and time. Analgesic options include heating pad, acetaminophen, percocet (oxycodone), fentanyl 0.5-1 mcg/kg.
Fentanyl: 0.5, 1 mcg/kg
Acetaminophen: Single + Oxycodone
Oxycodone: With Acetaminophen
|
|---|---|
|
Overall Study
STARTED
|
100
|
|
Overall Study
COMPLETED
|
100
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction
Baseline characteristics by cohort
| Measure |
Analgesia Options
n=100 Participants
Protocolized analgesia based on VAS degree of discomfort and time. Analgesic options include heating pad, acetaminophen, percocet (oxycodone), fentanyl 0.5-1 mcg/kg.
Fentanyl: 0.5, 1 mcg/kg
Acetaminophen: Single + Oxycodone
Oxycodone: With Acetaminophen
|
|---|---|
|
Age, Continuous
|
35.54 years
STANDARD_DEVIATION 4.61 • n=99 Participants
|
|
Sex: Female, Male
Female
|
100 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
5 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
95 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Asian
|
5 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Black or African American
|
5 Participants
n=99 Participants
|
|
Race (NIH/OMB)
White
|
90 Participants
n=99 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
PRIMARY outcome
Timeframe: PACU admission, 15, 30 and 60 min postprocedure, postoperative day 3Population: On PACU admission, subjects were divided into three groups based on the intensity of discomfort. A standardized postoperative analgesic regimen followed, based on VAS score and time (≤ or \> than 30 min).
Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale). VAS scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort.
Outcome measures
| Measure |
Analgesia Options
n=100 Participants
Protocolized analgesia based on VAS degree of discomfort and time. Analgesic options include heating pad, acetaminophen, percocet (oxycodone), fentanyl 0.5-1 mcg/kg.
Fentanyl: 0.5, 1 mcg/kg
Acetaminophen: Single + Oxycodone
Oxycodone: With Acetaminophen
|
|---|---|
|
Amount of Discomfort
Time 0; ≤10 Follicles
|
1.53 units on a scale
Standard Deviation 2.13
|
|
Amount of Discomfort
Time 0; > 10 Follicles
|
3.25 units on a scale
Standard Deviation 2.9
|
|
Amount of Discomfort
Time 15; ≤10 Follicles
|
2.68 units on a scale
Standard Deviation 2.19
|
|
Amount of Discomfort
Time 15; >10 Follicles
|
3.61 units on a scale
Standard Deviation 1.98
|
|
Amount of Discomfort
Time 30; ≤10 Follicles
|
1.66 units on a scale
Standard Deviation 1.40
|
|
Amount of Discomfort
Time 30; >10 Follicles
|
2.93 units on a scale
Standard Deviation 1.43
|
|
Amount of Discomfort
Time 60; ≤10 Follicles
|
0.97 units on a scale
Standard Deviation 1.16
|
|
Amount of Discomfort
Time 60; >10 Follicles
|
2.19 units on a scale
Standard Deviation 1.55
|
|
Amount of Discomfort
Time POD 3; ≤ 10 Follicles
|
1.44 units on a scale
Standard Deviation 1.15
|
|
Amount of Discomfort
Time POD 3; > 10 Follicles
|
1.64 units on a scale
Standard Deviation 1.82
|
SECONDARY outcome
Timeframe: After 1 hrs but less than 3 daysPopulation: All 100 parturients analyzed; divided into those who had less than, compared to more than 10 follicles on preoperative ultrasound image.
Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale) after immediate postoperative period (1 hrs) but prior to Embryo Transfer on 3rd postoperative day. Visual Analogue Scale (VAS) scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort. Patients will record the type, dose, and timing of pain medicines in a diary to be returned at Embryo Transfer.
Outcome measures
| Measure |
Analgesia Options
n=100 Participants
Protocolized analgesia based on VAS degree of discomfort and time. Analgesic options include heating pad, acetaminophen, percocet (oxycodone), fentanyl 0.5-1 mcg/kg.
Fentanyl: 0.5, 1 mcg/kg
Acetaminophen: Single + Oxycodone
Oxycodone: With Acetaminophen
|
|---|---|
|
Amount of Discomfort Following Discharge Until Embryo Transfer
POD1; ≤10 Folli
|
2.15 units on a scale
Standard Deviation 1.72
|
|
Amount of Discomfort Following Discharge Until Embryo Transfer
POD1; >10 Follicles
|
3.21 units on a scale
Standard Deviation 1.87
|
|
Amount of Discomfort Following Discharge Until Embryo Transfer
POD2; ≤10 Folli
|
1.28 units on a scale
Standard Deviation 1.89
|
|
Amount of Discomfort Following Discharge Until Embryo Transfer
POD2; >10 Folli
|
2.50 units on a scale
Standard Deviation 2.35
|
Adverse Events
Analgesia Options
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Lawrence Tsen, MD
Brigham and Women's Hospital/Harvard Medical School
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place